Related Experiment Videos
Further immunological studies of sera containing anti-mitochondrial antibodies, type M 5
Abstract:
All of 15 sera containing anti-mitochondrial antibodies (AMA), type M 5, reacted in ELISA with ssDNA, whereas only four had anti-nuclear antibodies as demonstrated by immunofluorescence technique. Twelve of 15 had biological false-positive seroreaction for syphilis and seven of 11 cases investigated had a positive lupus anti-coagulant test. Cold agglutinins were present in 11 sera. Hyper-gamma-globulinaemia was not a prominent finding, but C4 values below the lower limit were common in spite of C3 within the normal range. Absorption of IgG fractions from three different sera with cardiolipin eliminated the reaction with ssDNA and mitochondria, supporting a certain degree of cross-reactivity among the antibodies. The presence of AMA, type M 5, seemed to discriminate a group of patients with symptoms often consistent with SLE although some of the most prominent findings were often absent.
Insights
Anti-mitochondrial antibodies (AMA), type M 5, show cross-reactivity with ssDNA and are associated with symptoms resembling lupus erythematosus. These findings suggest AMA M 5 may indicate a specific patient subset.
Area of Science:
- Immunology
- Autoimmunity
- Rheumatology
Background:
- Anti-mitochondrial antibodies (AMA) are associated with autoimmune liver diseases.
- The clinical significance of AMA, type M 5, remains incompletely understood.
- Cross-reactivity between antibodies and cellular components can complicate diagnostic interpretations.
Purpose of the Study:
- To investigate the reactivity of anti-mitochondrial antibodies (AMA), type M 5, with ssDNA.
- To explore the association of AMA M 5 with other autoantibodies and clinical features.
- To determine if AMA M 5 can identify a specific patient group with autoimmune symptoms.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to detect antibody reactions with ssDNA.
- Immunofluorescence technique was employed to identify anti-nuclear antibodies.
- Tests for biological false-positive seroreaction for syphilis, lupus anticoagulant, and cold agglutinins were performed.
- Complement component C4 and C3 levels were analyzed.
- Immunoglobulin G (IgG) fractions were absorbed with cardiolipin to assess antibody cross-reactivity.
Main Results:
- All 15 sera with AMA M 5 reacted with ssDNA.
- Only four sera showed anti-nuclear antibodies by immunofluorescence.
- A majority of patients had positive lupus anticoagulant tests and cold agglutinins.
- Low C4 complement levels were common, despite normal C3 levels.
- Absorption studies indicated cross-reactivity between antibodies to cardiolipin, ssDNA, and mitochondria.
Conclusions:
- AMA M 5 demonstrates significant cross-reactivity with ssDNA.
- The presence of AMA M 5 may identify patients with symptoms overlapping with systemic lupus erythematosus (SLE).
- AMA M 5 could serve as a potential biomarker for a distinct clinical subset, even in the absence of typical SLE manifestations.